82 related articles for article (PubMed ID: 26942921)
1. Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer.
Fujimoto J; Alam SM; Jahan I; Sato E; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Cancer Sci; 2006 Sep; 97(9):861-7. PubMed ID: 16805819
[TBL] [Abstract][Full Text] [Related]
2. A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update.
Magar AG; Morya VK; Kwak MK; Oh JU; Noh KC
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542288
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8.
Liu LB; Xie F; Chang KK; Li MQ; Meng YH; Wang XH; Li H; Li DJ; Yu JJ
Int J Clin Exp Pathol; 2014; 7(2):575-83. PubMed ID: 24551277
[TBL] [Abstract][Full Text] [Related]
4. HDAC1 suppresses radiotherapy sensitivity in cervical cancer via regulating HIF-1α/VEGF signaling pathway.
Liu L; Gu K; Hua D
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):132-140. PubMed ID: 38015530
[TBL] [Abstract][Full Text] [Related]
5. Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells.
Zhang X; Luo H
Oncol Lett; 2018 Mar; 15(3):3313-3320. PubMed ID: 29435073
[TBL] [Abstract][Full Text] [Related]
6. Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid.
Datta S; Verma P; Dhara B; Kundu R; Maitra S; Mitra AK; Khan MS; Zughaibi TA; Tabrez S; Kumer A
J Cell Mol Med; 2024 Apr; 28(8):e18302. PubMed ID: 38652115
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acids in cancer pathogenesis.
Feitelson MA; Arzumanyan A; Medhat A; Spector I
Cancer Metastasis Rev; 2023 Sep; 42(3):677-698. PubMed ID: 37432606
[TBL] [Abstract][Full Text] [Related]
8. N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting Apoptosis.
Guo W; Jing W
Drugs R D; 2023 Jun; 23(2):165-174. PubMed ID: 37266883
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy.
Psilopatis I; Garmpis N; Garmpi A; Vrettou K; Sarantis P; Koustas E; Antoniou EA; Dimitroulis D; Kouraklis G; Karamouzis MV; Marinos G; Kontzoglou K; Nonni A; Nikolettos K; Fleckenstein FN; Zoumpouli C; Damaskos C
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190151
[TBL] [Abstract][Full Text] [Related]
10. Tumors derived from lung cancer cells respond differently to treatment with sodium valproate (a HDAC inhibitor) in a chicken embryo chorioallantoic membrane model.
Diržiuvienė R; Šlekienė L; Palubinskienė J; Balnytė I; Lasienė K; Stakišaitis D; Valančiūtė A
Histol Histopathol; 2022 Dec; 37(12):1201-1212. PubMed ID: 35703146
[TBL] [Abstract][Full Text] [Related]
11. [MiR-600 suppresses HeLa cell proliferation by inhibiting hypoxia-inducible factor-1
Zhou X; Deng J; Zhang W; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Feb; 41(2):210-215. PubMed ID: 33624593
[TBL] [Abstract][Full Text] [Related]
12. Reactive Oxygen Species-Mediated Mitochondrial Dysfunction Triggers Sodium Valproate-Induced Cytotoxicity in Human Colorectal Adenocarcinoma Cells.
Anirudh BVM; Ezhilarasan D
J Gastrointest Cancer; 2021 Sep; 52(3):899-906. PubMed ID: 32880040
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with
Avallone A; Piccirillo MC; Di Gennaro E; Romano C; Calabrese F; Roca MS; Tatangelo F; Granata V; Cassata A; Cavalcanti E; Maurea N; Maiolino P; Silvestro L; De Stefano A; Giuliani F; Rosati G; Tamburini E; Aprea P; Vicario V; Nappi A; Vitagliano C; Casaretti R; Leone A; Petrillo A; Botti G; Delrio P; Izzo F; Perrone F; Budillon A
Ther Adv Med Oncol; 2020; 12():1758835920929589. PubMed ID: 32849914
[TBL] [Abstract][Full Text] [Related]
14.
Sixto-López Y; Rosales-Hernández MC; Contis-Montes de Oca A; Fragoso-Morales LG; Mendieta-Wejebe JE; Correa-Basurto AM; Abarca-Rojano E; Correa-Basurto J
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824279
[No Abstract] [Full Text] [Related]
15. siRNA directed against Annexin II receptor inhibits HeLa cell proliferation, migration and invasion and induces apoptosis via suppressing ERK1/2 and Akt signaling pathways.
Cao ZJ; Xu XH; Gao T; Zhang Y; Xia H; Zhao YQ; Wang JJ
Int J Clin Exp Pathol; 2018; 11(1):88-98. PubMed ID: 31938090
[TBL] [Abstract][Full Text] [Related]
16. Effects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane.
Afzal E; Alinezhad S; Khorsand M; Khoshnood MJ; Takhshid MA
Iran J Med Sci; 2018 Sep; 43(5):506-513. PubMed ID: 30214103
[TBL] [Abstract][Full Text] [Related]
17. Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching.
Murugavel S; Bugyei-Twum A; Matkar PN; Al-Mubarak H; Chen HH; Adam M; Jain S; Narang T; Abdin RM; Qadura M; Connelly KA; Leong-Poi H; Singh KK
Front Pharmacol; 2018; 9():737. PubMed ID: 30050438
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals.
Zhao Y; You W; Zheng J; Chi Y; Tang W; Du R
Clin Transl Oncol; 2016 Nov; 18(11):1123-1130. PubMed ID: 26942921
[TBL] [Abstract][Full Text] [Related]
19. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
Jeong JH; Jeong YJ; Cho HJ; Shin JM; Kang JH; Park KK; Park YY; Chung IK; Chang HW; Magae J
J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
